Bromelain ameliorates D-galactosamine-induced acute liver injury: role of SIRT1/LKB1/AMPK, GSK3β/Nrf2 and NF-κB p65/TNF-α/caspase-8,-9 signalling pathways

MA Didamoony, AM Atwa… - Journal of Pharmacy …, 2022 - academic.oup.com
Objectives The present research focused on estimating, for the first time, the potential
protective effects of bromelain against D-galactosamine-induced acute liver injury in rats as …

[HTML][HTML] Shikonin protects against D-Galactosamine and lipopolysaccharide-induced acute hepatic injury by inhibiting TLR4 signaling pathway

MX Lin, YX Yi, PP Fang, SS Huang, CW Pan, LX Jin… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Shikonin, a naphthoquinone isolated from the root of medical herb Lithospermum
erythrorhizon, has been reported to have anti-inflammatory effect. However, there is no …

[PDF][PDF] Glycyrrhizin improves inflammation and apoptosis via suppressing HMGB1 and PI3K/mTOR pathway in lipopolysaccharide-induced acute liver injury.

CH Shen, ZY Ma, JH Li, RD Li, YF Tao… - European Review for …, 2020 - europeanreview.org
OBJECTIVE: Acute liver injury (ALI) is mainly characterized by the symptom of metabolic
disorders, homeostasis unbalance, and loss of liver function. There are no effective …

Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic …

L Dong, L Yin, H Quan, Y Chu, J Lu - Molecules, 2017 - mdpi.com
Fulminant hepatic failure (FHF), associated with high mortality, is characterized by extensive
death of hepatocytes and hepatic dysfunction. There is no effective treatment for FHF …

[HTML][HTML] Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling …

F Tang, K Fan, K Wang, C Bian - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Acute liver injury (ALI) is a life-threatening syndrome accompanied by overwhelming
inflammation. Amygdalin (AGD) has been reported to possess various biological activities …

Methyl 3,4-dihydroxybenzoate protects against d-galN/LPS-induced acute liver injury by inhibiting inflammation and apoptosis in mice

X Wang, L Wu, Q Zhang, L Li, Y Xie… - Journal of Pharmacy …, 2019 - academic.oup.com
Objectives Aimed to investigate the effect and mechanism of methyl 3, 4-dihydroxybenzoate
(MDHB) on d-galactosamine/lipopolysaccharide (d-galN/LPS)-induced acute liver failure …

4-hydroxybenzo [d] oxazol-2 (3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice

H Wang, X Wei, X Wei, X Sun, X Huang, Y Liang… - International …, 2020 - Elsevier
The purpose of this study was to synthesize 4-hydroxybenzo [d] oxazol-2 (3H)-one (HBO)
and to investigate its protective effects on lipopolysaccharide (LPS)/D-galactosamine (D …

Hepatoprotective effects of syringin on fulminant hepatic failure induced by D‐galactosamine and lipopolysaccharide in mice

X Gong, L Zhang, R Jiang, CD Wang… - Journal of Applied …, 2014 - Wiley Online Library
The prognosis for fulminant hepatic failure (FHF) still remains extremely poor with a high
mortality and, therefore, better treatments are urgently needed. Syringin, a main active …

Baicalein inhibits nuclear factor-κB and apoptosis via c-FLIP and MAPK in D-GalN/LPS induced acute liver failure in murine models

YL Wu, LH Lian, Y Wan, JX Nan - Chemico-biological interactions, 2010 - Elsevier
The hepatoprotective effects and molecular mechanisms of baicalein on acute liver failure
induced by d-galactosamine (d-GalN)/lipopolysaccharides (LPS) were investigated in vivo …

[HTML][HTML] Ginsenoside Rb1 reduces D-GalN/LPS-induced acute liver injury by regulating TLR4/NF-κB signaling and NLRP3 Inflammasome

Y Liu, N Liu, Y Liu, H He, Z Luo, W Liu… - Journal of Clinical and …, 2022 - ncbi.nlm.nih.gov
Methods Mice were pretreated with ginsenoside Rb1 by intraperitoneal injection for 3 days
before D-GalN/LPS treatment, to induce ALI. The survival rate was monitored every hour for …